focus -WSS

focus

author：knowledge 2025-10-02 00:42:59 - browse：24716

Boston Scientific headquarters -- Health coverage from STAT — Boston Scientific is growing its urology portfolio with the Axonics acquisition. Steven Senne/AP

Boston Scientific said it will buy Axonics, a device company treating urinary and bowel disorders, on Monday. The deal is worth $3.7 billion.

It’s the first billion-dollar medical device deal of 2024 — a rare occurrence in 2023, which saw just a handful of medtech acquisitions reaching the billion threshold. Boston Scientific said it expects to close the deal in the first half of this year. Axonics’ stock increased by 20% in light of the news; Boston Scientific’s dropped slightly.

Boston Scientific has acquired companies across all medtech sectors in the past year. The device maker bought Apollo Endosurgery, a company selling surgical tools to combat obesity, for $615 million in 2023. In September of 2023, Boston Scientific bought pain relief company Relievant for $850 million.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： As demand for Covid shots wanes, Moderna seeks its next success
Next article： STAT Health News: mRNA flu shots, Purdue SCOTUS case, etc

WSS

Helping hospitals and community health centers plan for resilience

Criminal prosecution for violating HIPAA: an emerging threat

Despite FDA approval for Lyfgenia, Bluebird faces stiff competition

Spinal cord stimulation reduces pain in amputees, study finds

Chemotherapy shortages won’t get better under Biden’s latest plan

Helping hospitals and community health centers plan for resilience

hotspot

focus

focus

State Dept. review finds Biden bears some blame for Afghanistan failures

AI models in health care face new federal disclosure requirements

Bright Health sells Medicare Advantage business to Molina

Can we make enough H5N1 bird flu vaccine if there's a pandemic?

The high cost of giving birth even with insurance

Leukemia patients are helped by Syndax's new type of therapy

Trump demands the U.S. pay no more for drugs than other countries … again

Venture capitalist Bob Kocher on the state of digital health

Virginia high school admissions case could be legal follow

The woman behind the Dana Farber

hotspot

Teach medical students about patients with intellectual disabilities

Roche to buy Carmot Therapeutics, developer of obesity drugs

Radiology is caught between AI's potential and concern for patients

CMS should re

The woman behind the Dana Farber

After sickle

hotspot

explore

entertainment

focus